Everand Logo

Welcome to Everand!

  • The European Business Review

    FINDING NEW PRODUCTS BY VISION: Eurodrug innovates in a sector dominated by “big pharma”

    Mar 31, 2020 4 minutes

    How does a medium-sized company stand out in a highly concentrated market with rapidly increasing capital requirements? Eurodrug is an international pharmaceutical company active in more than 30 countries, with a differentiated portfolio and a unique business model. They follow a vision that has pushed them to create their own innovative products, developed in Europe and backed by European research. With more than 30 years of experience, the company is growing rapidly in ways that others are still experimenting with.

    Eurodrug Laboratories is a privately owned company that has managed to become a key player in several therapeutic areas globally.

    “Since the company’s founding in the early eighties, it has successfully brought its products to over 30 countries, predominantly throughout Asia, Latin America and CIS countries, with a focus

    You’re reading a preview, subscribe to read more.

    More from The European Business Review

    The European Business Review5 min read
    PARTNERSHIP AND TECHNOLOGY: Solving Municipal Solid Waste Management in Developing Economies
    A common comparison on walking the streets of developed versus developing economies is witnessing garbage in the streets. This is observed in the South Asian and African regions due to weak and inadequate municipal solid waste management (MSWM) pract
    The European Business Review7 min read
    You Did Not Fail! You Are Just Rebounding!
    The hidden side of such achievement is also common to all entrepreneurs: failure. According to the Bureau of Lahor Statistics1, in the US, at least 20% of businesses will fail in their first two years, and up to almost 50% will do so by age five. The
    The European Business Review8 min readIntelligence (AI) & Semantics
    Cultivating Executive Trust In The Age Of AI Governance
    As artificial intelligence becomes more embedded across sectors, governments respond with new regulations to manage risks while enabling innovation. However, complex and fragmented regulatory approaches could undermine trust in AI among key decision-

    Related Books & Audiobooks